This compound is a protected peptide intermediate used in the manufacturing of carfilzomib, a pharmaceutical agent. It features a complex structure containing multiple amide bonds, an aromatic ring system, and a morpholine moiety.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 868540-16-3
(S)-Methyl 2-((S)-4-Methyl-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMido)-3-phenylpropanoate
pharmaceutical intermediate
L-Phenylalanine, (alphaS)-alpha-[[2-(4-morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-, phenylmethyl ester
research compound
Carfilzomib
pharmaceutical raw material
(S)-4-Methyl-N-((R)-1-(((S)-4-Methyl-1-((R)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)aMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide
pharmaceutical intermediate
5-Chloropyridine-2-carboxylic acid
pharmaceutical intermediate
Acetyl octapeptide-3
pharmaceutical intermediate
Diethylaminoethyl chloride hydrochloride
pharmaceutical intermediate
4-Chloro-3-iodo-1H-pyrrolo[2,3-b]pyridine
pharmaceutical intermediate
(2S)-2-[[(2S)-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanoyl]amino]-3-phenylpropanoic acid
MIVQDKORYUSPTQ-QKDODKLFSA-N
CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC2=CC=CC=C2)NC(=O)CN3CCOCC3